Skip to main content
Kasia Lipska, MD, Endocrinology, New Haven, CT

KasiaJLipskaMD

Endocrinology New Haven, CT

Diabetes, Lipid Metabolism

Assistant Professor of Medicine (Endocrinology), Yale School of Medicine

Telehealth Available

Overview of Dr. Lipska

I am an endocrinologist at the Yale School of Medicine and a Clinical Investigator at the Yale-New Haven Hospital Center for Outcomes Research and Evaluation (CORE). My research program seeks to better understand the balance of benefits and harms of glucose-lowering therapy in older adults with type 2 diabetes. My current research projects are primarily focused on severe hypoglycemia. I am investigating trends in admissions for hypoglycemia among the elderly Medicare population; race, sex, and age disparities in these admissions; using qualitative research methods to explore reasons for hypoglycemia admissions; examining key risk factors for hypoglycemia; and developing prediction models for hypoglycemia. Based on these data, I seek to develop and implement decision support tools to help clinicians and patients make better decisions about their care. My overall goals are to generate data that patients and clinicians need—data which currently do not exist—so that they can make better, smarter treatment decisions.

In addition, Dr. Lipska works at CORE on the development of ambulatory care quality measures for the Centers for Medicare & Medicaid Services (CMS). She is currently leading the development of an outcome measure of care quality among people with diabetes mellitus.

Education & Training

  • Yale-New Haven Hospital
    Yale-New Haven HospitalPost-Doctoral Fellowship, 2009 - 2011
  • Yale University
    Yale UniversityM.H.Sc., 2011
  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 2007 - 2009
  • Brigham and Women's Hospital
    Brigham and Women's HospitalResidency, Internal Medicine, 2003 - 2006
  • Harvard Medical School
    Harvard Medical SchoolClass of 2003
  • Yale University
    Yale UniversityB.S., Molecular Biochemistry and Biophysics, Cum Laude, 1997

Certifications & Licensure

  • CT State Medical License
    CT State Medical License 2012 - 2025
  • MA State Medical License
    MA State Medical License 2006 - 2007
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • Young Investigator Career Development Award in Geriatric Endocrinology ADA-ASP, 2013
  • Grants for Early Medical/Surgical Specialists’ Transition to Aging (GEMSSTAR) Award 2013
  • Pepper Research Career Development Core Scholar Award 2013
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Comparative Effectiveness of Generic vs Brand-Name Levothyroxine in Achieving Normal Thyrotropin Levels  
    Juan P Brito, Robert C Smallridge, Victor Bernet, Kasia J Lipska, JAMA Network Open
  • Is the Over-the-Counter Availability of Human Insulin in the United States Good or Bad?  
    Kasia J. Lipska, Madeline McCrary, JAMA
  • Availability and Affordability of Essential Medicines: Implications for Global Diabetes Treatment  
    Kasia Lipska, Irl B. Hirsch, Current Diabetes Reports
  • Join now to see all

Lectures

  • Lilacs, Lactate, Lies, and Labels 
    1/1/2016
  • Type 2 Diabetes in Older Patients 
    1/1/2016
  •  
    New Orleans, LA - 1/1/2016
  • Join now to see all

Other

  • Break up the insulin racket 
    Lipska K, The New York Times
    1/20/2016
  • When diabetes treatment goes too far 
    Lipska K, The New York Times
    1/12/2015
  • The global diabetes epidemic 
    Lipska K, The New York Times
    1/25/2014
  • Join now to see all

Press Mentions

  • Infection Monitoring Needed for Older Adults with Elevated A1C
    Infection Monitoring Needed for Older Adults with Elevated A1COctober 28th, 2024
  • Ahead of Senate Hearing, Doctors Decry 'Exorbitant' Cost of Ozempic and Wegovy
    Ahead of Senate Hearing, Doctors Decry 'Exorbitant' Cost of Ozempic and WegovySeptember 16th, 2024
  • Ahead of Novo Nordisk Hearing, 250 Clinicians Demand Affordable Access to Ozempic and Wegovy
    Ahead of Novo Nordisk Hearing, 250 Clinicians Demand Affordable Access to Ozempic and WegovySeptember 16th, 2024
  • Join now to see all